Vertex Minerals continues to steadily increase the rate of stoping at Reward gold mine, delivering ore grade material and ...
Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...
Vertex Inc. (NASDAQ: VERX) and CPA.com announced an expanded partnership that brings artificial intelligence deeper into the ...
Data presented at ASH suggest that the CRISPR therapy could provide a one-time functional cure in children as young as 5 years old, researchers said.
KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...
Vertex Announces Third Quarter 2025 Financial Results And $150 Million Class A Common Stock Repurchase Program. KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) ...
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex (VRTX) to submit first module before end of year - - Second pivotal ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein ...
As a long-time Oracle partner, Vertex will continue to leverage Oracle technologies to drive customer success globally KING OF PRUSSIA, June 10, 2025(NASDAQ:VERX) ("Vertex" or the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback